Medical Devices Late Stage Investors & VC Firms
489 firms in this list, with a median first check of $1.1M. 105 of them lead rounds. Generated from verified public data and updated continuously.
Navivo Capital
WarsawSeries A–Late Stage
3 people
Teuza
HaifaPre-Seed–Late Stage$250K – $2M
5 people
Gilmartin Capital LLC
LarkspurSeries A–Late Stage
2 people
Hellman & Friedman
San FranciscoGrowth–Late Stage
2 people
Aescuvest
Frankfurt am MainSeed–Late Stage
1 person
Frontier Path VC
LondonGrowth–Late Stage
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
Darwin Venture Management
TaipeiSeed–Late Stage$1M – $76M
Hony Capital Ltd.
Hong KongGrowth–Late Stage$6M
6 people
Innovation Engine
TokyoPre-Seed–Late Stage
3 people
JAFCO Group
TokyoPre-Seed–Late Stage$1.9M – $198M
BioRock Ventures
San FranciscoPre-Seed–Late Stage
1 person
Mayo Clinic Ventures
RochesterSeed–Late Stage
2 people
MB Venture Partners
MemphisPre-Seed–Late Stage
2 people
Nissay Capital
TokyoPre-Seed–Late Stage$610K – $71M
1 person
Reverent Partners
SeoulSeries A–Late Stage
venture / science
San Francisco Bay AreaSeed–Late Stage
2 people
Lundbeckfonden Ventures
CopenhagenPre-Seed–Late Stage
1 person
NJF Capital
LondonSeed–Late Stage
1 person
Aurum Ventures MKI
Ramat GanSeed–Late Stage
8 people
Trans-Pacific Technology Fund
TaipeiSeed–Late Stage
8 people
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Pura Vida Investments
New YorkLate Stage
Fjord Ventures
Laguna HillsSeed–Late Stage
1 person
Related lists
Late Stage Investors & VC Firms (2974)Late Stage Investors & VC Firms in North America (1695)Late Stage Investors & VC Firms in United States (1516)Medical Devices Investors & VC Firms (1452)Medical Devices Seed Investors & VC Firms (1202)Medical Devices Series A Investors & VC Firms (1187)Late Stage Investors & VC Firms in Europe (965)Medical Devices Investors & VC Firms in North America (948)Healthtech Late Stage Investors & VC Firms (925)Late Stage Investors & VC Firms in Global (904)
Data sourced from public filings and firms' own websites — see our methodology.
























